Skip to main content

Scotland Plans To Boycott TVM Use For Pelvic Surgery

Scotland Plans To Boycott TVM Use For Pelvic Surgery

Scotland Plans To Boycott TVM Use For Pelvic Surgery

Introduction

As the complications related to transvaginal mesh used to treat pelvic prolapse and stress urinary incontinence continues to build up, Scotland takes measures to put a temporary ban on using the mesh for surgical procedures. The Holyrood Public Petition Committee has filed a request with the Scottish Parliament referring that vaginal mesh implants should be barred from use in Scotland.

The petition comes following United Kingdom's suspension of the device after recommendations by the Independent Medicines and Medical Devices Safety Review and the U.K. Department of Health and Social Care and National Health Service (NHS) England. C.R. Bard, Ethicon Inc., Boston Scientific and other manufacturers face lawsuits over design flaws in their vaginal mesh implants causing severe internal injuries to women across the U.S. and U.K. The FDA states that there is no additional benefit of using the transvaginal mesh in comparison to other traditional methods of treating pelvic prolapse.

Lawsuits included in the multidistrict litigation (MDL) formed over Transvaginal mesh (TVM) complications are overlooked by Judge Joseph R. Goodwin in the Southern District of West Virginia for consolidated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.